The International Myeloma Foundation has started a first-of-its-kind national clinical research network aiming to expand access to clinical trials and improve care for people…

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the investigational therapy onvansertib as a potential treatment for chronic myelomonocytic leukemia…

I sit on the edge of the chair beside her bed and choose my words with care. The doctor has just shared an update about…